Autoimmune And Inflammation Allergy

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Allergy Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Allergy Projects
--Allergy Therapeutics plc
--ALK-Abello A/S
--Boehringer Ingelheim GmbH
--Biogen Idec Inc
--Cytos Biotechnology AG
--Curalogic A/S
--GlaxoSmithKline plc
--Fornix Biosciences N.V.
--Meiji Seika Kaisha, Ltd.
--Kyorin Co., Ltd.
--NicOx S.A.
--Menarini Group
--Nycomed
--Nippon Shinyaku Co., Ltd.
--Ranbaxy Laboratories Ltd.
--Paladin Labs Inc.
--Schering-Plough Corp
--Resistentia Pharmaceuticals AB
--Teijin Pharma Limited
--Taisho Pharmaceutical Co., Ltd.

--Top Companies in early stage Allergy Projects
--Alkermes Inc
--ALK-Abello A/S
--Amgen Inc
--Allergy Therapeutics plc
--CyDex Pharmaceuticals, Inc.
--Atopix Pharmaceuticals Corporation
--Dynavax Technologies Corp
--DAIICHI SANKYO COMPANY, LIMITED
--Genesis Research & Development Corporation Limited
--EpiGenesis Pharmaceuticals Inc
--ImVisioN GmbH
--Hunter-Fleming Ltd
--Kyowa Hakko Kogyo Co., Ltd.
--KAKEN PHARMACEUTICAL CO., LTD.
--REGiMMUNE Corporation
--Novavax Inc
--Sanofi-Aventis
--Samyang Corporation
--Stallergenes
--Schering-Plough Corp

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View